A flow cytometry-based immuno-titration assay for rapid and accurate titer determination of modified vaccinia Ankara virus vectors.

作者: Zengji Li , Loni Ling , Xiaohui Liu , Reiner Laus , Alain Delcayre

DOI: 10.1016/J.JVIROMET.2010.07.003

关键词: Molecular biologyBiologyTiterVacciniaModified vaccinia AnkaraVirus quantificationPoxviridaeTransducing UnitVirologyOrthopoxvirusVirus

摘要: A flow cytometry-based immuno-titration titer assay was established to determine infectious unit (IU) and transducing (TU) of modified vaccinia Ankara (MVA) virus vectors. This titration method enumerates infected cells by measuring the expression viral protein for IU transgene TU in individual after staining with fluorophore-conjugated antibodies. It presents many advantages over standard approaches, such as TCID(50) or plaque assay, its convenience, rapidity accuracy illustrated excellent linearity reproducibility. Importantly, assays generated similar batch-specific values when testing varied MVA-derived preparations. Assay development revealed that post-infection time at which is evaluated, host cell type, blocking formation release progeny virion nocodazole, an anti-microtubule agent rifampin, a specific assembly inhibitor, are critical parameters precision, robustness, determination. An added advantage this it enables concurrent determination units product recombinant viruses. The latter demonstrated using MVA vector carrying human HER-2 gene fragment model. Hence, very versatile can be used well multiple titers simultaneously. Furthermore, readily adapted other poxvirus

参考文章(23)
Hillar O. Kangro, Brian W. J. Mahy, Virology methods manual Academic Press. ,(1996)
Valéry Renard, Lene Sonderbye, Kirsten Ebbehøj, Peter Birk Rasmussen, Klaus Gregorius, Tine Gottschalk, Søren Mouritsen, Anand Gautam, Dana R. Leach, HER-2 DNA and Protein Vaccines Containing Potent Th Cell Epitopes Induce Distinct Protective and Therapeutic Antitumor Responses in HER-2 Transgenic Mice Journal of Immunology. ,vol. 171, pp. 1588- 1595 ,(2003) , 10.4049/JIMMUNOL.171.3.1588
Stuart Neal Isaacs, Vaccinia virus and poxvirology : methods and protocols Humana Press. ,(2004)
Caroline Staib, Ingo Drexler, Gerd Sutter, Construction and Isolation of Recombinant MVA Methods of Molecular Biology. ,vol. 269, pp. 77- 100 ,(2004) , 10.1385/1-59259-789-0:077
Ann Chahroudi, David A. Garber, Patrick Reeves, Luzheng Liu, Daniel Kalman, Mark B. Feinberg, Differences and similarities in viral life cycle progression and host cell physiology after infection of human dendritic cells with modified vaccinia virus Ankara and vaccinia virus. Journal of Virology. ,vol. 80, pp. 8469- 8481 ,(2006) , 10.1128/JVI.02749-05
G. Antoine, F. Scheiflinger, F. Dorner, F.G. Falkner, THE COMPLETE GENOMIC SEQUENCE OF THE MODIFIED VACCINIA ANKARA STRAIN : COMPARISON WITH OTHER ORTHOPOXVIRUSES Virology. ,vol. 244, pp. 365- 396 ,(1998) , 10.1006/VIRO.1998.9123
Linda Shonk Weaver, Michael J. Kadan, Evaluation of Adenoviral Vectors by Flow Cytometry Methods. ,vol. 21, pp. 297- 312 ,(2000) , 10.1006/METH.2000.1010
BERNARD MOSS, EDITH N. ROSENBLUM, EHUD KATZ, PHILIP M. GRIMLEY, Rifampicin: a specific inhibitor of vaccinia virus assembly. Nature. ,vol. 224, pp. 1280- 1284 ,(1969) , 10.1038/2241280A0
Zun-Ren Chan, Chia-Wei Lai, Hsiao-Ping Lee, Huang-Chi Chen, Yu-Chen Hu, Determination of the baculovirus transducing titer in mammalian cells. Biotechnology and Bioengineering. ,vol. 93, pp. 564- 571 ,(2006) , 10.1002/BIT.20749